abstract |
A feature of the invention relates to compounds, compositions and methods useful for modulating the expression of vascular endothelial growth factor (VEGF), such as by RNA interference (RNAi) mechanisms. The compounds and compositions of the invention include an iRNA agent that may be in an unmodified state or in a chemically modified state. |